Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas

Journal of Surgical Oncology

Volumn 97, Issue 1, 2008, Pages 74-81

  Itakura, Eijun ^a,b   Yamamoto, Hidetaka ^a   Oda, Yoshinao ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Skin neoplasms; Soft tissue neoplasms; Stewart Treves syndrome; Vascular neoplasms; VEGF A; VEGF C; VEGFR 3

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ANGIOSARCOMA; CANCER PATIENT; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SCALP; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38149060090     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20766     Document Type: Conference Paper

References (47)

1. Maddox JC, Evans HL: Angiosarcoma of skin and soft tissue: A study of forty-four cases. Cancer 1981;48:1907-1921.
2. Mark RJ, Poen JC, Tran LM, et al.: Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996;77:2400-2406.
3. Billingsley KG, Burt ME, Jara E, et al.: Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:602-610; discussion 610-612.
4. Bocklage T, Leslie K, Yousem S, et al.: Extracutaneous angiosarcomas metastatic to the lungs: Clinical and pathologic features of twenty-one cases. Mod Pathol 2001;14:1216-1225.
5. Girard C, Johnson WC, Graham JH: Cutaneous angiosarcoma. Cancer 1970;26:868-883.
6. Karpeh MS Jr., Caldwell C, Gaynor JJ, et al.: Vascular soft-tissue sarcomas. An analysis of tumor-related mortality. Arch Surg 1991;126:1474-1481.
7. Fong Y, Coit DG, Woodruff JM, et al.: Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993;217:72-77.
8. Behranwala KA, A'Hern R, Omar AM, et al.: Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 2004;11:714-719.
9. Stewart FW, Treves N: Lymphangiosarcoma in postmastectomy lymphedema: A report of six cases in elephantiasis chirurgica. Cancer 1948;1:64-81.
10. Woodward AH, Ivins JC, Soule EH: Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 1972;30:562-572.
11. Weiss SW, Goldblum JR: Malignant vascular tumors. In: Weiss SW, Goldblum JR, (eds): "Enzinger and Weiss's soft tissue tumors". St. Louis, MO: Mosby, 2001:917-954.
12. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al.: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999;154:385-394.
13. Fukunaga M: Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005;46: 396-402.
14. Kahn HJ, Bailey D, Marks A: Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Modern Pathol 2002;15:434-440.
15. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858.
16. Shibuya M, Yamaguchi S, Yamane A, et al.: ,Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990;5:519-524.
17. de Vries C, Escobedo JA, Ueno H, et al.: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
18. Matthews W, Jordan CT, Gavin M, et al.: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A 1991;88:9026-9030.
19. Millauer B, Wizigmann-Voos S, Schnurch H, et al.: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72:835-846.
20. Stacker SA, Achen MG, Jussila L, et al.: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-583.
21. Takeda A, Stoeltzing O, Ahmad SA, et al.: Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol 2002;9:610-616.
22. Hashimoto M, Ohsawa M, Ohnishi A, et al.: Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab Invest 1995;73:859-863.
23. Brown LF, Tognazzi K, Dvorak HF, et al.: Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996;148:1065-1074.
24. Fujimoto M, Kiyosawa T, Murata S, et al.: Vascular endothelial growth factor in angiosarcoma. Anticancer Res 1998;18:3725-3729.
25. Galland F, Karamysheva A, Pebusque MJ, et al.: The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 1993;8:1233-1240.
26. Joukov V, Pajusola K, Kaipainen A, et al.: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298.
27. Achen MG, Jeltsch M, Kukk E, et al.: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A 1998;95:548-553.
28. Cross MJ, Dixelius J, Matsumoto T, et al.: VEGF-receptor signal transduction. Trends Biochem Sci 2003;28:488-494.
29. Achen MG, McColl BK, Stacker SA: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7:121-127.
30. Lymboussaki A, Partanen TA, Olofsson B, et al.: Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998;153:395-403.
31. Huang HY, Ho CC, Huang PH, et al.: Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Lab Invest 2001;81:1729-1734.
32. Saito T, Oda Y, Itakura E, et al.: Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor. Pathol Int 2001;51:532-542.
33. Amo Y, Masuzawa M, Hamada Y, et al.: Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res 2001;293:296-301.
34. Arbiser JL, Larsson H, Claesson-Welsh L, et al.: Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol 2000;156:1469-1476.
35. Ilan N, Tucker A, Madri JA: Vascular endothelial growth factor expression, beta-catenin tyrosine phosphorylation, and endothelial proliferative behavior: A pathway for transformation? Lab Invest 2003;83:1105-1115.
36. Moyer C, Allen D, Basabe A, et al.: Analysis of vascular endothelial growth factor (VEGF) and a receptor subtype (KDR/flk-1) in the liver of rats exposed to riddelliine: A potential role in the development of hemangiosarcoma. Exp Toxicol Pathol 2004;55:455-465.
37. Partanen TA, Alitalo K, Miettinen M: Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-2412.
38. Folpe AL, Veikkola T, Valtola R, et al.: Vascular endothelial growth factor receptor-3 (VEGFR-3): A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000;13:180-185.
39. Skobe M, Brown LF, Tognazzi K, et al.: ,Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma. J Invest Dermatol 1999;113:1047-1053.
40. Dumont DJ, Jussila L, Taipale J, et al.: Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998;282:946-949.
41. Wilting J, Neeff H, Christ B: Embryonic lymphangiogenesis. Cell Tissue Res 1999;297:1-11.
42. Wilting J, Papoutsi M, Becker J: The lymphatic vascular system: Secondary or primary? Lymphology 2004;37:98-106.
43. Scavelli C, Vacca A, Di Pietro G, et al.: Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054-1058.
44. Monroe AT, Feigenberg SJ, Mendenhall NP: Angiosarcoma after breast-conserving therapy. Cancer 2003;97:1832-1840.
45. Holden CA, Spittle MF, Jones EW: Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987;59:1046-1057.
46. Grobmyer SR, Daly JM, Glotzbach RE, et al.: Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome). J Surg Oncol 2000;73:182-188.
47. Roy P, Clark MA, Thomas JM: Stewart-Treves syndrome - Treatment and outcome in six patients from a single centre. Eur J Surg Oncol 2004;30:982-986.